8:30 AM-11:55 AM
Moderator
-
杜舟, 华平投资副总监
-
Joe DU, Associate Director of Warburg Pincus
8:30 AM-9:00 AM
-
开场报告
-
Keynote Speech
-
挖掘专利数据,助力新药研发
-
Mining patent data, Assisting drug discovery
-
胡元佳,澳门大学中药质量研究国家重点实验室医药信息中心副主任
-
HU Yuanjia,Deputy Director of University of Macau, Medical Informatics Center, State Key Laboratory of Quality Research in Chinese Medicine
9:00 AM-9:25 AM
-
项目1
-
Project 1
-
歌礼制药新药研发管线介绍与肿瘤脂质代谢最新研发进展
-
update for the pipeline of Ascletis Pharma Inc. and the interoduction of Patients with Recurrent Glioblastoma
-
吴劲梓,歌礼制药有限公司创始人、董事会主席兼首席执行官
-
WU Jinzi, Founder、Chairman and CEO of ASCLETIS PHARMA INC.
9:25 AM-9:50 AM
-
项目2
-
Project 2
-
研发、合作多点突破,创新产品线价值显现
-
Various Breakthroughs in R&D and Cooperation, Innovative Efforts Start to Generate Value
-
杨亮, 绿叶制药投资者关系与公共关系副总裁
-
Allen YANG, Vice President of Investor Relations and Public Relations of Luye Pharma
9:50 AM-10:15 AM
-
项目3
-
Project 3
-
华领医药未来研发管线展望
-
Introduction of future pipeline——Hua Medicine
-
陈力, 华领医药董事长、首席执行官、创始人、首席科学官
-
CHEN Li,Executive Director, Chief Executive Officer, Founder and Chief Scientific Officer of Hua Medicine
10:15 AM-10:40 AM
-
项目4
-
Project 4
-
新赛生,新动能
-
A New SciClone with New Momentum
-
郭晓宁, 赛生药业控股有限公司副总裁,研发负责人兼首席医学官
-
GUO Xiaoning,Vice President, Head of R&D and CMO of SciClone Pharmaceuticals (Holdings) Limited
10:40 AM-11:05 AM
-
项目5
-
Project 5
-
贝达的创新与发展
-
From One to Unlimited:Betta's Innovation and Development
-
吴灵犀, 贝达药业股份有限公司董事长助理兼董事会秘书
-
WU Lingxi,Chairman Assistant & Board Secretary of Betta Pharmaceuticals Co., Ltd.
11:05 AM-11:30 AM
-
项目6
-
Project 6
-
亚盛医药 专注细胞凋亡研发创新药物
-
Ascentage Pharma Group-Advancing Therapies That Restore Apoptosis
-
杨大俊, 中国药促会药物研发专业委员会主任委员、亚盛医药董事长兼CEO
-
YANG Dajun, Chairman of PhIRDA Drug R&D Specialty Committee、Chairman of the Board & CEO of Ascentage Pharma
11:30 AM-11:55 AM
-
项目7
-
Project 7
-
远大医药-打造国际一流的肿瘤核素诊疗创新平台
-
GP(HK) builds up a world-leading innovation platform for oncology diagnosis and treatment
-
周超, 远大医药健康控股有限公司行政总裁
-
Frank ZHOU,Chief Executive Officer of China Grand Pharmaceutical and Healthcare Holdings Limited
Specification:
- Released: September 17, 2020
- Last update: September 19, 2020
- Version: 1.1